Formulation: A crystalline solid
Pricing updated 2019-03-21. Prices are subject to change without notice.
The endocannabinoids present a rich system of central cannabinoid (CB1), peripheral cannabinoid (CB2), and non-
Warning - this product is not for human or veterinary use.
View our Base Peak Identification Tool
View our Flipbook Identification Tool
View the Cayman Structure Database for chemical structure definitions for many Cayman products
View the Cayman Spectral Library (CSL) for ChemStation-searchable GC-MS spectra of many of Cayman's emerging forensic drug standards
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data pack, and GC-MS data.
1. Pertwee, R.G. Pharmacology of cannabinoid receptor ligands Curr. Med. Chem. 6(8), 635-664 (1999).
2. Martin, B.R., Mechoulam, R., and Razdan, R.K. Discovery and characterization of endogenous cannabinoids Life Sciences 65, 573-595 (1999).
Jüttler, E., Potrovita, I., Tarabin, V., et al. The cannabinoid dexanabinol is inhibitor of the nuclear factor-
Ciolino, L.A. Quantitation of synthetic cannabinoids in plant materials using high performance liquid chromatography with UV detection (validated method) J.Forensic Sci. 60(5), 1171-1181 (2015).